Company Filing History:
2 out of 9 
2 out of 94 
Years Active: 2009-2010
Title: Clive Maurice Gray: Innovator in HIV Research
Introduction
Clive Maurice Gray is a notable inventor based in Johannesburg, South Africa. He has made significant contributions to the field of HIV research, particularly in the development of innovative solutions aimed at combating the virus. With a focus on regulatory and accessory genes, Gray's work has implications for vaccine development and therapeutic strategies.
Latest Patents
Gray holds 2 patents related to HIV-1 subtype isolate regulatory and accessory genes. His latest patents describe the tat, nef, and rev genes, along with their modifications and derivatives. The inventions also disclose consensus amino acid sequences and relate to a vaccine that includes two or more nucleotide sequences, as well as sequences from the pol and/or gag genes of HIV-1. These advancements represent a crucial step in the ongoing battle against HIV.
Career Highlights
Throughout his career, Clive Maurice Gray has worked with esteemed institutions such as the South African Medical Research Council and the University of Cape Town. His research has been pivotal in understanding the complexities of HIV and developing potential vaccines.
Collaborations
Gray has collaborated with notable colleagues, including Carolyn Williamson and Joanne Heidi Van Harmelen. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Clive Maurice Gray's contributions to HIV research through his patents and collaborations highlight his role as an innovator in the field. His work continues to inspire advancements in medical science and public health.